Research Article
Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial
Table 2
Composite endpoints of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke (intention-to-be-treat analyses).
| Composite endpoints | QSYQ () | Aspirin () | HR (95% CI) | value | HR (95% CI) Adjusted for gender | value Adjusted for gender |
| 12-month treatment completed | Composite endpoints | 52 (2.98%) | 52 (2.96%) | 1.02 (0.69, 1.50) | 0.928 | 1.03 (0.70, 1.52) | 0.872 | Cardiovascular death | 28 (1.60%) | 23 (1.31%) | 1.24 (0.71, 2.15) | 0.450 | 1.26 (0.73, 2.19) | 0.411 | Nonfatal MI | 18 (1.03%) | 19 (1.08%) | 0.97 (0.51, 1.84) | 0.917 | 0.98 (0.51, 1.87) | 0.952 | Nonfatal stroke | 6 (0.34%) | 10 (0.57%) | 0.61 (0.22, 1.68) | 0.340 | 0.61 (0.22, 1.68) | 0.339 |
| 6-month followup after study drugs terminated | Composite endpoints | 64 (3.67%) | 67 (3.81%) | 0.98 (0.69, 1.38) | 0.895 | 0.99 (0.70, 1.40) | 0.957 | Cardiovascular death | 31 (1.78%) | 30 (1.71%) | 1.05 (0.64, 1.74) | 0.836 | 1.07 (0.65, 1.77) | 0.782 | Nonfatal MI | 26 (1.49%) | 26 (1.48%) | 1.03 (0.60, 1.77) | 0.925 | 1.04 (0.60, 1.79) | 0.891 | Nonfatal stroke | 7 (0.40%) | 11 (0.63%) | 0.65 (0.25, 1.68) | 0.373 | 0.65 (0.25, 1.68) | 0.377 |
|
|